Search Results 391-400 of 14868 for anti-TNF drugs

1. Estrogen And Progestin Oral Contraceptives (Oral Route) Proper Use - Mayo Clinic

   You then take tablets of a second strength (color) for the next eleven or fourteen days, depending on the medication prescribed (the second phase). At this ...

2. New progress in development of gene therapy for arthritis - Mayo Clinic

   Treatment of arthritis is limited by the pharmacokinetics of joints, which impede the sustained, intra-articular delivery of therapeutic agents.

3. Predicting Clinical Response to HER2-Targeted Therapy - Hormones and Cancer Laboratory

   Although the prognosis for such patients is generally poor, the use of humanized monoclonal anti-HER2 antibodies, such as trastuzumab, has resulted in long-term ...

4. Oxtriphylline And Guaifenesin (Oral Route) Before Using - Mayo Clinic

   Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... medicines. Adinazolam; Alprazolam ...

5. Codeine (Oral Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

6. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

   Use of anti-inflammatory medications listed below within the last 30 days: Leflunomide; Sulfasalazine; Mycophenolate; Cyclosporine; Cyclophosphamide ...

7. Pegfilgrastim-Bmez (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Pegfilgrastim-bmez injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

8. Antifungal, Azole (Vaginal Route) Precautions - Mayo Clinic

   Vaginal medicines usually will come out of the vagina during treatment. To keep the medicine from getting on your clothing, wear a minipad or sanitary napkin.

9. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

   * Any cytotoxic chemotherapy or other anticancer drugs for the treatment ... * Seizures requiring a change in anti-epileptic medications (addition of new ...

10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Drugs & Supplements A-Z · Health ... Is naïve to biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.